CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- 4 Planned sale CVP,Strategy/Corp Development sold 11,340 shares at $85.93 ($974,430)
- 4 Open-market sale CVP,Strategy/Corp Development sold 24,000 shares at $83.84 ($2,012,076)
- 4 Shares withheld for taxes CVP, TAVR gave up 432 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corporate Controller gave up 176 shares (to pay taxes)
- 4 Shares withheld for taxes CVP, Chief Financial Officer gave up 199 shares (to pay taxes)
- 4 Shares withheld for taxes CVP, TAVR gave up 456 shares (to pay taxes)
- 4 Open-market sale CEO sold 22,430 shares at an average $76.67 ($1,719,741)
- 4 Planned sale CVP, TAVR sold 1,019 shares at $85.70 ($87,332)
- 4 Planned sale CVP,Strategy/Corp Development sold 11,340 shares at an average $85.66 ($971,429)
- 4 Open-market sale CVP,Strategy/Corp Development sold 11,386.12 shares at an average $83.76 ($953,748)
- 4 Planned sale CVP, JAPAC sold 1,019 shares at $84.03 ($85,625)
- 4 Open-market sale Director sold 2,615 shares at $83.41 ($218,120)
- 4 Open-market sale CVP, TMTT & Surgical sold 2,000 shares at $84.38 ($168,750)
- 4 Planned sale CVP,Strategy/Corp Development sold 11,340 shares at $83.83 ($950,581)
- 4 Planned sale CEO sold 25,350 shares at an average $84.95 ($2,153,373)
- 4 Planned sale CVP, Chief Financial Officer sold 7,700 shares at $84.47 ($650,412)
- 4 Open-market sale CVP, JAPAC sold 583 shares at $86.01 ($50,144)
- 4 Grant or award SVP, Corporate Controller acquired 1,160 shares (grant or award)
- 4 Planned sale CVP, Chief Financial Officer sold 13,000 shares at an average $83.08 ($1,080,093)
- 4 Planned sale CVP, JAPAC sold 1,020 shares at $82.55 ($84,196)
Page 4 of 94 · 1,865 filings